Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Bystolic
Bystolic
AbbVie notches reprieve in antitrust case involving blood pressure med snagged in $63B Allergan megamerger
Fierce Pharma
Wed, 01/26/22 - 11:00 am
AbbVie
antitrust
Bystolic
generics
Allergan
The top 10 drugs losing U.S. exclusivity in 2021
Fierce Pharma
Wed, 03/10/21 - 10:59 pm
patents
Lucentis
Bystolic
Vascepa
Narcan
Brovana
Sutent
Saphris
Amitza
Feraheme
Forest recalls another 90,000-plus bottles of Bystolic
Fierce Pharma Manufacturing
Tue, 11/4/14 - 01:59 pm
Forest Labs
product recalls
Bystolic
Forest Labs Seeks Bystolic-Diovan Approval
Yahoo/Zacks.com
Tue, 03/4/14 - 10:22 pm
Bystolic
Diovan
Forest Labs
hypertension
Forest Labs says trial results positive for hypertension drug
Reuters
Thu, 06/27/13 - 10:07 am
Forest Labs
Bystolic
Forest Labs says Bystolic approved in Canada
Yahoo/AP
Sat, 01/19/13 - 12:10 pm
Forest Labs
Bystolic
Canada
Forest Labs says Canadian regulators approved its high blood pressure drug Bystolic
Yahoo/AP
Fri, 01/18/13 - 10:15 am
Forest Labs
Canada
antihypertensives
Bystolic
Forest Labs Settles BYSTOLIC Patent Lawsuit
Motley Fool
Fri, 01/4/13 - 11:49 am
Bystolic
patents
Forest Labs
settlements
Forest Laboratories, Inc. Announces Settlement Agreement with Hetero Labs Ltd. in BYSTOLIC® Patent Litigation
Business Wire
Sat, 10/27/12 - 12:25 pm
Forrest
Hetero Labs
Bystolic
generics
patents
lawsuits
Forest buys hypertension drug rights from J&J
Reuters
Mon, 04/2/12 - 10:50 am
Forest
JNJ
antihypertensives
Bystolic
Forest Laboratories Receives Decision From FDA For Supplemental New Drug Application For Bystolic(R)
Medical News Today
Sat, 02/27/10 - 12:44 pm
Forrest
Bystolic
heart failure
FDA panel rejects new use for Forest heart drug
Yahoo/AP
Mon, 01/11/10 - 09:13 pm
FDA
Forest Labs
Bystolic
US FDA staff against wider approval of Forest drug
Reuters
Thu, 01/7/10 - 11:06 am
Forest Labs
FDA
Bystolic